'A single night' beneficial effects of adaptive servo-ventilation on cardiac overload, sympathetic nervous activity, and myocardial damage in patients with chronic heart failure and sleep-disordered breathing.
BACKGROUND
Sleep-disordered breathing (SDB), including Cheyne-Stokes respiration with central sleep apnea (CSR-CSA), causes a deterioration in the prognosis of patients with chronic heart failure (CHF). Adaptive servo-ventilation (ASV) and oxygen therapy (O(2)) are useful for improving the CSR-CSA of CHF. The purpose of the present study was to examine the short-term effects of ASV and O(2) on suppressing SDB (CSR-CSA dominant) in CHF, and the accompanying neurohumoral abnormalities (cardiac overload, sympathetic nervous activation, and myocardial damage).


RESULTS
FORTY-two patients with CHF and SDB (mean LVEF 34.6%, apnea hypopnea index (AHI) 39.0/h, central apnea index (CAI) 17.6/h, obstructive apnea index (OAI) 2.6/h) were enrolled. We performed polysomnography (baseline, O(2), and ASV) for 3 consecutive days, and we measured levels of atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), noradrenalin, urinary catecholamines, and high-sensitivity troponin T. Both O(2) and ASV reduced the AHI, CAI, arousal index, mean heart rate during sleep, and the levels of noradrenalin, urinary catecholamines, and high-sensitivity troponin T. However, only ASV, not O(2), decreased the levels of ANP and BNP.


CONCLUSIONS
ASV reduces cardiac overload, attenuates sympathetic nervous activity and ongoing myocardial damage effectively in CHF patients with SDB, and for patients who cannot use ASV, O(2) is an alternative therapy.
Department of Advanced Cardiac Therapeutics, Fukushima Medical University, Fukushima, Japan. yoshihis@fmu.ac.jp
Akiomi
A
Yoshihisa
Satoshi
S
Suzuki
Makiko
M
Miyata
Takayoshi
T
Yamaki
Koichi
K
Sugimoto
Hiroyuki
H
Kunii
Kazuhiko
K
Nakazato
Hitoshi
H
Suzuki
Shu-ichi
S
Saitoh
Yasuchika
Y
Takeishi
D000368:Aged; D009320:Atrial Natriuretic Factor / Q000097:blood; D002908:Chronic Disease; D018592:Cross-Over Studies; D005260:Female; D006333:Heart Failure / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009206:Myocardium; D010100:Oxygen / Q000008:administration & dosage*; D020181:Sleep Apnea, Obstructive / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000503:physiopathology*; D020107:Troponin T / Q000097:blood
D020107:Troponin T; D009320:Atrial Natriuretic Factor; D010100:Oxygen